Wednesday, January 23, 2019

Investorideas.com - Putting their Pawprint on the #CBD #Pet Industry - SinglePoint (OTCQB: $SING), Charlotte's Web (CSE: $CWEB.C), Canopy Growth ( TSX: $WEED.TO) (NYSE: $CGC) and CannTrust (TSX: $TRST.TO)

Investorideas.com - Putting their Pawprint on the #CBD #Pet Industry - SinglePoint (OTCQB: $SING), Charlotte's Web (CSE: $CWEB.C), Canopy Growth ( TSX: $WEED.TO) (NYSE: $CGC) and CannTrust (TSX: $TRST.TO)

Putting their Pawprint on the #CBD #Pet Industry - SinglePoint (OTCQB: $SING), Charlotte's Web (CSE: $CWEB.C), Canopy Growth (TSX: $WEED.TO) (NYSE: $CGC) and CannTrust (TSX: $TRST.TO)

CBD Pet-and-animal product sales are estimated to reach $125 million by 2022

Point Roberts, WA and Delta, BC - January 23, 2019 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases part one of a two- part series looking at the future of the CBD Pet Market and the companies looking to take a bite out of the growing global pet industry.

The US pet industry expenditures are estimated at 72.13 billion for 2018 according to the American Pet Products Association and the global pet care market is expected to reach USD 202.6 billion by 2025. Combine that with New Frontier Data reporting, "Pet-and-animal product sales are estimated to reach $125 million by 2022, representing a 5-year CAGR of 57%, among the fastest-growing sectors in the CBD market" and it's easy to see why cannabis companies are pouncing on the opportunity.

Seeing the way of the future, in August 2018 Canopy Animal Health, a division of Canopy Growth Corporation (TSX:WEED.TO) (NYSE:CGC) that focuses on healthcare products for companion animals, received approval from the Veterinary Drug Directorate to research the possible therapeutic effects of cannabidiol on anxiety.

Canopy Animal Health notes on its website, "While the existence of cannabinoids has been known for centuries, the concept of using naturally occurring cannabinoids as therapeutics for companion animals is a new forefront of medical discovery."

Now a growing number of CBD manufacturers are beginning to take notice and develop their own lines of pet products, especially after the reclassification of CBD in the US.

SingleSeed.com, a subsidiary of SinglePoint (OTCQB: SING), a company with a history in the cannabis market recently launched PHYTO-BITES on SingleSeed.com. The company's subsidiary SingleSeed.com has added a new vertical, serving pet owners with a brand-new offering that is formulated to reduce stress, pain, separation anxiety and inflammation. PHYTO-BITES is manufactured and supplied by CBD Unlimited, formerly Endexx. The two companies are working collaboratively to distribute this product online and in stores all over the nation.

GrandView Research, looking at the global pet care market notes that based on type, dogs held the largest market share. SinglePoint (OTCQB: SING) strategically plans to make PHYTO-BITES one of its premier offerings because of the size of the market and the market penetration potential.

Looking at entering the pet market as part of the company's overall growth strategy in the cannabis sector, Greg Lambrecht, CEO of SinglePoint said, "We are very excited to add this to our list of products. The pet market is a tremendous opportunity and we plan to attend and use all our contacts to promote this product at every opportunity we are presented with."

Also going after the dog market, Charlotte's Web Holdings, Inc., (CSE:CWEB) (OTC: CWBHF) describes their pet product line saying, "Our high quality hemp extract with easily digestible and healthy MCT oil helps dogs to maintain a sense of calm plus support for their active hips and joints. Contains 16.5mg of CBD per mL."

Charlotte's Web full product line includes CBD Oil tinctures, CBD capsules, CBD topicals, as well as CBD pet products, which will require a large quantity of consistent hemp product available as these markets take off.

From dogs to wolves…In April 2018, CannTrust Holdings Inc. (TSX:TRST.TO), one of Canada's leading licensed producers of medical cannabis, announced that it entered into a letter of intent with Grey Wolf Animal Health Inc. to develop groundbreaking cannabis products to support the well-being of pets.

Grey Wolf Animal Health Inc. announced that it has acquired Veterinary Healthcare Solutions Inc. to accelerate the growth of Grey Wolf's business and complements its existing portfolio of specialty animal health products for the veterinary channel. The transaction is immediately accretive to both revenue and EBITDA and provides Grey Wolf with a portfolio of commercial products and a national sales force platform to support its pipeline of current and future products. Financial terms of the deal were not disclosed.

As CBD products for pets become more available and pet owners become more accepting of the benefits, investors can expect this to become a more competitive landscape. This may lead to a parallel path of the CBD beverage industry with big-name brands partnering and seeking acquisitions.

Continued in Part 2; Investorideas.com will explore some of the other companies looking to get their teeth into this sector and what's driving this market.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

https://www.investorideas.com/About/

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

This news is published on the Investorideas.com Newswire - News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring SING is a paid for news release on Investorideas.com. Learn more about costs and our services https://www.investorideas.com/News-Upload/

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com

800-665-0411

Investorideas.com - Retail #Investors Ahead of Institutional Investors in #Cannabis Stocks - (OTC: $HIPH) (NYSE: $CGC) (NYSE: $APHA) (NASDAQ: $CRON) (NASDAQ: $TLRY)

Retail #Investors Ahead of Institutional Investors in #Cannabis Stocks - (OTC: $HIPH) (NYSE: $CGC) (NYSE: $APHA) (NASDAQ: $CRON) (NASDAQ: $TLRY)

Point Roberts, WA and Delta, BC - January 23, 2019 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing trend of institutional coverage and funding in the cannabis sector and how a once frowned upon industry is now the big-boys new 'darling'.

In any industry that builds success, history shows the little companies lead innovation and take the risk and once the value proposition is proven, the big companies step in to grab their share. The same can hold true for investing; small retail investors see the big picture before the institutional investors - and never has this pattern been more true than with the cannabis sector.

Retail investors can pat themselves on the back following Friday's news that CIBC's Institutional Equity Research team initiated coverage on Canopy Growth (TSX: WEED.TO) ( NYSE: CGC) , Cronos (TSX: CRON.TO)(NASDAQ: CRON) and Aphria (TSX: AHPA.TO) (NYSE: APHA).

In their report, 'Cannabis: The Beginning of a Global Seismic Shift', they stated:

Our Conclusion: "Investors rarely get to witness the birth of an industry. Such historic events include the gold rush, inventions of the automobile and aircraft, and the internet. In most instances, investors rush to pour capital into the sector, and while the industries develop, very few companies live up to their lofty expectations. We expect cannabis to follow this course. Dozens of small/medium-sized firms will likely earn moderate revenues and earnings, but our view is that only a handful will come to dominate the global market. We believe Canopy and Cronos are likely to be two of those winners; meanwhile, we view Aphria as a manufacturing and automation expert, but believe concerns about capital allocation and corporate governance could deter investors. Effective January 17, we initiate coverage of Canopy Growth with an Outperformer rating and $65 price target; Cronos Group, with an Outperformer rating and $22 price target; and Aphria, with a Neutral rating and $10 price target."

Retail investors usually see a bump in the share price once the bigger institutional investors step in and that was definitely the case following the January 15th news from CBD beverage company, American Premium Water Corporation (OTC: HIPH) that it had entered into a financing agreement with an institutional investor at a $0.40 valuation, ten times the current market valuation. As part of the agreement, a substantial portion of the Company's convertible debt will be retired. The retirement will be reflected in the Company's 1st quarter 2019 financials.

American Premium CEO, Ryan Fishoff, commented, "I am thrilled to announce that the Company has entered into this agreement at a 10x valuation! This is an affirmation of the Company's business plan and the initiatives it has implemented over the past year. It's a vote of confidence to the direction of the Company and we will continue to work hard to execute on the business plan to achieve the goals and benchmarks that I laid out for 2019. There is still a tremendous amount of work to do, but we (the Company) are certainly emboldened by this financing agreement, which will give the Company the capital to implement its 2019 plan. This agreement also meets the Company's goal to reduce convertible debt and strengthen the balance sheet. This is a win for the Company and our shareholders."

Piper Jaffray analyst Michael Lavery also joined the pro-cannabis ranks in early January, initiating coverage of Tilray (NASDAQ: TLRY) and Canopy Growth (TSX: WEED.TO) ( NYSE: CGC) saying, "We do believe the long-term growth opportunities are significant - both from transitioning illicit trade to legal sales, medical sales, and from transitioning sales in health & wellness categories to CBD-infused products." Canopy Growth rose 13 percent following the news.

TLRY ( NASDAQ: TLRY) also gained over 19.% mid-January following news that its largest shareholder, Privateer Holdings, led by venture capitalist Peter Thiel, co-founder of PayPal, would not sell their shares until the first half of 2019.

So it's clear the impact institutional investors have in the market, but their entry into the cannabis market is still just limited to a handful of players. Retail investors can bet there are more to come.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring HIPH is a paid for news release on Investorideas.com - third party , Learn more about costs and our services https://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com

800-665-0411

Investorideas.com - "Get Your #CBD On" - #Cannabis Stocks to Watch; (OTC: $ISBG) (NASDAQ: $NBEV) (CSE: $KBEV.C) (CSE: $GGB.C)

"Get Your #CBD On" - #Cannabis Stocks to Watch; (OTC: $ISBG) (NASDAQ: $NBEV) (CSE: $KBEV.C) (CSE: $GGB.C)

Point Roberts, WA and Delta, BC - January 23, 2019 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the influx of CBD product purchase orders announced in 2019 as the demand for CBD products grows.

CBD continues to be the largest "buzz-word" in the cannabis sector and companies are wasting no time stocking their shelves with a diverse CBD product line-up as 2019 begins.

New Age Beverages Corp. (NASDAQ:NBEV), an organic and natural beverage company is betting on branding and name recognition to help take on the U.S. CBD-infused drinks market. In their recent press release, they announced that they have signed an agreement to develop and distribute Bob Marley cannabis beverages.

From the news: "The first product to rollout in the Marley+CBD portfolio will be Marley+CBD Mellow Mood, relaxation drinks in 15.5 oz cans with 25 mg of pharmaceutical grade CBD per serving. Initial market rollout to customers will be in Colorado, Oregon, Washington, and Michigan where cannabis is legal for responsible adult consumption."

Continued: "Retailers and distributors realize that it will be a long road for smaller CBD brands to gain traction and brand equity. Under the Marley brand platform, we are able to leverage a massive global brand with ties to healthy cannabis use, to ultimately grow a beverage brand beyond anything we have seen to date," said Michael Cunningham, Senior Vice President of sales for New Age.

Smaller, but just as ambitious, International Spirits and Beverage Group Inc. (OTC: ISBG), a brand incubator in the Global Wine & Spirits and CBD-Infused products markets recently announced its first purchase order for the Company’s new P19 CBD Gummies. The order exceeds $115K. In addition, the Company now anticipates revenues from its recently launched Health and Wellness segment to top $300K during Q1 2019 based on orders for CBD Gummies and other new product releases.

That would represent potential annualized y/y growth of 233% following full-year 2018 billed sales of $360K in comparable items and services.

ISBG CEO, Terry Williams, stated, "The removal of hemp from federal prohibition under the Controlled Substances Act of 1970 will, according to all analysis we have received, indeed mean a broad expansion in the scale and scope of the total U.S. hemp industry. And experts expect this to have a dramatic and disproportionately positive impact on growth in the hemp-derived CBD products market segment. We expect this to be a major performance driver for ISBG Health and Wellness in 2019."

"With our expansion into the CBD products space, we now have enough logistical complexity to materially streamline costs through the implementation of our new supply chain technology," continued Mr. Williams. "Everything is suddenly coming together right now for this Company – the Farm Bill, strong early growth in our new Health and Wellness division, our Besado overhaul, our integration of our hybrid supply chain management system."

Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) another cannabis company in the CBD and beverage space announced its first purchase order with GNC Holdings, Inc. (GNC), a leading global health and wellness brand with thousands of retail stores across the U.S. and Canada.

It is the largest single order for product that Koios has received in its corporate history, and is for Koios's four most popular flavors, which will initially be available for purchase in approximately 2,700 GNC retail stores in the U.S. before the end of Q1, 2019.

Another company, Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) announced their recent agreement with DSW Inc. to sell hemp-derived CBD personal care products under the Seventh Sense Botanical Therapy brand at select DSW stores throughout the U.S.

The Agreement was received for 54,960 units and covers sales in 96 U.S.-based DSW stores.

The Agreement follows a successful test phase conducted last autumn in which Green Growth Brands sold select Seventh Sense products in 10 DSW stores in which 74.4% of product presented on shelves was sold during the first 10 weeks of the test period.

2019 looks to be a big year for CBD products, with headlines in USA Today reporting, "Cannabis food, drinks to be 2019's hottest dining trend, top chefs say." If all goes according to analyst predictions, this could be a year of " Don’t Worry, Be Happy" for the sector.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring ISBG is a paid for news release on Investorideas.com. Learn more about costs and our services https://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com

800-665-0411

Tuesday, January 22, 2019

Investorideas.com - #Cannabisstocks: Harvest Health & Recreation Inc. (CSE: HARV, OTCQX: HTHHF) Now Trading on OTCQX

Investorideas.com - #Cannabisstocks: Harvest Health & Recreation Inc. (CSE: HARV, OTCQX: HTHHF) Now Trading on OTCQX

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (CSE: $AGRO.C) (TSX-V: $OGO.V) (OTC: $OGOFF) (CSE: $NTAR.C) (OTC: $NEXCF) (CSE: $FONE.C) (OTCQB: $FLOOF) (TSX: $TRST.TO)

Investorideas.com - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (CSE: $AGRO.C) (TSX-V: $OGO.V) (OTC: $OGOFF) (CSE: $NTAR.C) (OTC: $NEXCF) (CSE: $FONE.C) (OTCQB: $FLOOF) (TSX: $TRST.TO)

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (CSE: $AGRO.C) (TSX-V: $OGO.V) (OTC: $OGOFF) (CSE: $NTAR.C) (OTC: $NEXCF) (CSE: $FONE.C) (OTCQB: $FLOOF) (TSX: $TRST.TO)

Delta, Kelowna, BC - January 22, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2019/012219-StocksToWatch.mp3

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (CSE: $AGRO.C) (TSX-V: $OGO.V) (OTC: $OGOFF), (CSE: $NTAR.C) (OTC: $NEXCF), (CSE: $FONE.C) (OTCQB: $FLOOF) (TSX: $TRST.TO)

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:

Good afternoon and welcome to another Investorideas.com "potcast", looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we will be looking at announcements from Agrios Global Holdings Ltd. (CSE: AGRO), Organto Foods Inc. (TSX-V: OGO) (OTC: OGOFF), Cannvas MedTech Inc. (CSE: MTEC) (OTCPK: CANVF), NexTech AR Solutions Corp.(CSE: NTAR) (OTC: NEXCF), Flower One Holdings Inc. (CSE: FONE) (OTCQB: FLOOF) and CannTrust Holdings Inc. (TSX: TRST).

But first, Medicinal Genomics Corporation, a pioneer in using genomics to improve the transparency, safety and yield of cannabis has today announced the industry's most comprehensive Cannabis reference genome, a high quality de novo genome assembly of the Jamaican Lion cannabis strain. As the first reference genome to break the "usability barrier," the significance of this development cannot be overstated. Having a comprehensive cannabis genome opens the door to a host of industry innovations, including enabling cannabis research in states and countries where cannabis is still illegal, marker-assisted selection (MAS) for genetically-based strain identification, accelerated breeding to improve production yields, reliable seed-to-sale tracking systems, and pathogen identification to ensure cannabis purity and safety.

"For the first time, growers and breeders will have a complete and reliable genome from which to create new strains for increased yields and productivity, while documenting them to protect their work. Cultivators will also be able to embark on a brand new era of intelligent breeding destined to change the way cannabis is grown, sold and consumed," said Kevin McKernan, chief science officer for Medicinal Genomics. "And this is just the beginning of enhancing cannabis yield with genomics. This plant that has the potential to be more valuable than wheat and corn combined, but with far more varied and diverse uses, including everything from CO2 sequestration to pain relief and medical therapies to complete vegetable proteins, clothing and industrial materials."

MGC was the first to sequence the cannabis genome with its sequencing of the Chemdawg cultivar in 2011. Since then, major breakthroughs in sequencing technology have enabled their reference of the cannabis genome to greatly exceed the standards set by the Human Genome Project in 2001. The company has also steadily applied these improvements by adding more genomes to its Kannapedia knowledge database, and in 2018, in validation of the company's progress their work was underwritten by the DASH Cryptocurrency.

Agrios Global Holdings Ltd. announced it will be establishing a subsidiary business unit in the State of Missouri to provide consulting services related to the regulatory changes that come into affect with the state's recent approval of medical cannabis. The Company's initial focus is preparing license applications for qualified clients who wish to enter the emerging medical cannabis business in Missouri.

Agrios Global Holdings has been assessing the opportunity for expansion into Missouri pending the outcome of a proposed constitutional amendment, the Medical Marijuana and Veteran Healthcare Services Initiative, which was approved on November 6, 2018. The measure has legalized marijuana use for medical purposes under state law, but does not change federal law, which still makes marijuana possession, sale and cultivation a federal offense.

Agrios Global Holdings' Director, Larry Ellison, a long-time advocate of the recent changes to the Missouri marijuana legislation, commented, "Potential cultivation, manufacturing and dispensary license applicants will require the guidance of someone with a clear understanding of the regulatory environment under which marijuana can be cultivated in Missouri. Agrios will offer services to assist clients with license applications and can offer those who obtain licenses further advisory and consulting services in areas such as dispensary operations, agriculture technology and agronomy services for improving crop quality."

Organto Foods Inc. today announced that the Organto Global Cannabis Group, through its wholly-owned subsidiary, Medicannabis S.A.S. has filed registrations for a total of 144 cultivars (i.e., strains) and breeding lines as Fuente Semillera (translated, "Source Seed") with the Instituto Colombiano Agropecuario (ICA), Colombia's agricultural authority.

All cannabis plants grown in Colombia must be derived from registered Fuente Semillera in order to be permitted for use. Licensed cannabis producers had until December 31, 2018 to file these registrations. Medicannabis filed technical sheets for 144 cultivars and breeding lines in advance of the deadline thereby establishing a large and diverse genetic library for the company to cross-breed and develop numerous new cultivars with a wide variety of trait combinations (flavor, aroma, medicinal properties, phytochemistry, etc.).

"A large and broadly diverse genetic library is the foundation for a successful plant breeding program, key for the development of commercially successful varieties and product applications." commented Todd Dalotto, President of the Organto Global Cannabis Group. "Our Fuente Semillera library will allow us to create new cultivars with seemingly infinite combinations of traits that include phytochemistry (i.e., high/low-THC, high-CBD, THCV, CBG, and terpenes), mold-resistance, aromas, flavors, and suitability to various climates and growing environments."

Cannvas MedTech Inc., a leading digital cannabis educator and business technology company, announced it has agreed to a deal with NexTech AR Solutions Corp., whose mission is to bring augmented reality (AR) to the masses through its web-enabled AR e-commerce, AR e-learning and AR live streaming platforms to create the first AR ecosystem, to collaborate on enhancing the user experience of its digital cannabis education kiosks across Canada.

"Working with NexTech allows Cannvas the opportunity to create a first-to-market AR-based cannabis learning program and lead the way for the digital evolution of education as it continues to intertwine with technology to generate new and exciting ways for people to take in information," said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. "It has been proven that companies who personalize the user experience through AR enjoy an improvement in their customer relations and overall profitability, and our goal through this partnership with NexTech is to take our Cannvas Kiosk to the next level and ensure users receive accurate and evidence-based cannabis information customized to their needs and location."

NexTech brings AR to a wide audience through its own AR ecosystem, featuring e-commerce solutions for websites, AR learning and education and AR live streaming for events. Its AR web-enabled e-commerce platform is currently integrated with Shopify, WordPress and Magento, and its e-learning platform "edCetra" has been used by Fortune 500 companies such as Imperial Oil, Bombardier and Staples, as well as the Library of Congress and others to educate and train employees.

Flower One Holdings Inc. today announced a new licensing agreement and Brand Partnership for cannabis-product fulfillment in Nevada with California-based, Old Pal, the popular lifestyle cannabis brand that offers the most affordable legal cannabis in the state of California. Flower One is now licensed to produce, manufacture and distribute the entire Old Pal product line to Nevada's 130 cannabis retailers, marking Old Pal's first out-of-state expansion and entry into the Nevada market.

"Flower One is thrilled to bring a California favorite, Old Pal, to the Nevada market to ensure that our retail partners and, subsequently, consumers have access to quality, affordable and abundant cannabis flower," says Ken Villazor, President and CEO of Flower One. "As Flower One continues to secure more Brand Partners for the Nevada market, we remain focused on meeting the needs of all levels of the value chain, ranging from affordable 'shareable flower,' like Old Pal's suite of products, to high-end luxury products."

Rusty Wilenkin, Co-Founder & CEO of Old Pal has had his sights set on a Nevada expansion since his California sales started to soar, "California has already taken off and we're positive that our second market will see even more success. The opportunity in Nevada is huge, with 55 million tourists landing in Nevada every year we really have the chance to showcase our brand on an international stage."

CannTrust Holdings Inc., one of Canada's leading, most trusted licensed producers of cannabis and the 2018 Canadian Cannabis Awards "Top Licensed Producer of the Year", announced it has obtained the necessary permitting from the Town of Pelham to proceed with its Phase III expansion with the construction process set to commence immediately.

The revised Phase III expansion is permitted for a footprint of up to 390,000 square feet, compared to the 600,000 square feet in the Company's initial application. However, with enhancements to the Phase III facility above and beyond the specifications initially contemplated, CannTrust maintains its total production capacity forecast of 100,000 kg per year after completion of the Phase III construction.

The enhancements to the Phase III expansion include investing in automation and a higher level of climate control. Given these enhancements and the time it has taken to obtain permitting, construction of the Phase III expansion is expected to be complete in the third quarter of 2020. Initial harvest from the Phase III expansion is expected in the second quarter of 2020 and full production capacity is expected in the second half of 2020. In order to address local concerns from the emission of light from its facilities, CannTrust is proceeding to add additional fan ventilation so its shades can be completely closed, at minimal incremental cost.

Subscribe to the new cannabis podcast series:

https://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/

About Investorideas.com - News that Inspires Big Investing Ideas

Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Contact Investorideas.com

800-665-0411

Investorideas.com - "Get Your #CBD On" - From Drinks to Edibles, CBD is the Trend to Watch; (OTC: $ISBG) (NASDAQ: $NBEV) (CSE: $KBEV.C) (CSE: $GGB.C)

"Get Your #CBD On" - From Drinks to Edibles, CBD is the Trend to Watch; (OTC: $ISBG) (NASDAQ: $NBEV) (CSE: $KBEV.C) (CSE: $GGB.C)

Point Roberts, WA and Delta, BC - January 22, 2019 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the influx of CBD product purchase orders announced in 2019 as the demand for CBD products grows.

CBD continues to be the largest "buzz-word" in the cannabis sector and companies are wasting no time stocking their shelves with a diverse CBD product line-up as 2019 begins.

That would represent potential annualized y/y growth of 233% following full-year 2018 billed sales of $360K in comparable items and services.

The Agreement was received for 54,960 units and covers sales in 96 U.S.-based DSW stores.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com

800-665-0411

Investorideas.com - Retail Cannabis Investors Paved the Way for Institutional Investors to Jump in - How CIBC, Piper Jaffray and Peter Thiel are Playing a Role in Cannabis Stocks - (OTC: $HIPH) (NYSE: $CGC) (NYSE: $APHA) (NASDAQ: $CRON) (NASDAQ: $TLRY)

Investorideas.com - Retail Cannabis Investors Paved the Way for Institutional Investors to Jump in - How CIBC, Piper Jaffray and Peter Thiel are Playing a Role in Cannabis Stocks - (OTC: $HIPH) (NYSE: $CGC) (NYSE: $APHA) (NASDAQ: $CRON) (NASDAQ: $TLRY)

Retail Cannabis Investors Paved the Way for Institutional Investors to Jump in - How CIBC, Piper Jaffray and Peter Thiel are Playing a Role in Cannabis Stocks - (OTC: $HIPH) (NYSE: $CGC) (NYSE: $APHA) (NASDAQ: $CRON) (NASDAQ: $TLRY)

Point Roberts, WA and Delta, BC - January 22, 2019 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing trend of institutional coverage and funding in the cannabis sector and how a once frowned upon industry is now the big-boys new 'darling'.

In their report, 'Cannabis: The Beginning of a Global Seismic Shift', they stated:

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com

800-665-0411

about Investorideas.com

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .